Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $32.6600 (-14.26%) ($32.0500 - $34.2600) on Thu. May. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.15% (three month average) | RSI | 52 | Latest Price | $32.6600(-14.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.4% a day on average for past five trading days. | Weekly Trend | IOVA advances 2.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(46%) ARKG(45%) IWO(42%) ARKK(40%) | Factors Impacting IOVA price | IOVA will decline at least -4.075% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-13%) TBT(-5%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.075% (StdDev 8.15%) | Hourly BBV | 0 () | Intraday Trend | -1.6% | | | |
|
Resistance Level | $35.47 | 5 Day Moving Average | $37.46(-12.81%) | 10 Day Moving Average | $36.87(-11.42%) | 20 Day Moving Average | $35.47(-7.92%) | To recent high | -20.3% | To recent low | 67.1% | Market Cap | $4.783b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |